Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer

[1]  P. Mehlen,et al.  Dependence receptors: new targets for cancer therapy , 2021, EMBO molecular medicine.

[2]  T. Brabletz,et al.  Dynamic EMT: a multi‐tool for tumor progression , 2021, The EMBO journal.

[3]  R. Weinberg,et al.  Linking EMT programmes to normal and neoplastic epithelial stem cells , 2021, Nature Reviews Cancer.

[4]  Thea D. Tlsty,et al.  A framework for advancing our understanding of cancer-associated fibroblasts , 2020, Nature Reviews Cancer.

[5]  C. Lebbé,et al.  Netrin-1 and its receptor DCC are causally implicated in melanoma progression. , 2019, Cancer research.

[6]  J. Blay,et al.  A first in human, phase I trial of NP137, a first-in-class antibody targeting netrin-1, in patients with advanced refractory solid tumors , 2019, Annals of Oncology.

[7]  Pan‐Chyr Yang,et al.  Cancer-associated fibroblasts produce Netrin-1 to control cancer cell plasticity. , 2019, Cancer research.

[8]  Qi Wang,et al.  Netrin‑1 interference potentiates epithelial‑to‑mesenchymal transition through the PI3K/AKT pathway under the hypoxic microenvironment conditions of non‑small cell lung cancer. , 2019, International journal of oncology.

[9]  N. Renier,et al.  Long-Range Guidance of Spinal Commissural Axons by Netrin1 and Sonic Hedgehog from Midline Floor Plate Cells , 2019, Neuron.

[10]  Zena Werb,et al.  Roles of the immune system in cancer: from tumor initiation to metastatic progression , 2018, Genes & development.

[11]  Hong Chen,et al.  Netrin-1 elicits metastatic potential of non-small cell lung carcinoma cell by enhancing cell invasion, migration and vasculogenic mimicry via EMT induction , 2018, Cancer Gene Therapy.

[12]  R. Weinberg,et al.  EMT, CSCs, and drug resistance: the mechanistic link and clinical implications , 2017, Nature Reviews Clinical Oncology.

[13]  Peiqing Liu,et al.  Bradykinin promotes migration and invasion of hepatocellular carcinoma cells through TRPM7 and MMP2. , 2016, Experimental cell research.

[14]  Trushar R. Patel,et al.  Structural Decoding of the Netrin-1/UNC5 Interaction and its Therapeutical Implications in Cancers. , 2016, Cancer cell.

[15]  K. Tarte,et al.  Targeting netrin‐1/DCC interaction in diffuse large B‐cell and mantle cell lymphomas , 2016, EMBO molecular medicine.

[16]  P. Mehlen,et al.  Dependence Receptors and Cancer: Addiction to Trophic Ligands. , 2015, Cancer research.

[17]  Jaime Rodriguez-Canales,et al.  A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition , 2015, Clinical Cancer Research.

[18]  Peiyuan Li,et al.  Netrin-1 Induces Epithelial–Mesenchymal Transition and Promotes Hepatocellular Carcinoma Invasiveness , 2014, Digestive Diseases and Sciences.

[19]  C. Klein,et al.  Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death , 2013, EMBO molecular medicine.

[20]  N. Eritja,et al.  An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias , 2013, Disease Models & Mechanisms.

[21]  R. Deconti.  Chemotherapy of squamous cell carcinoma of the skin. , 2012, Seminars in oncology.

[22]  S. Calza,et al.  Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients , 2011, British Journal of Cancer.

[23]  Alain Chédotal,et al.  Novel roles for Slits and netrins: axon guidance cues as anticancer targets? , 2011, Nature Reviews Cancer.

[24]  J. Scoazec,et al.  Netrin-1 up-regulation in inflammatory bowel diseases is required for colorectal cancer progression , 2009, Proceedings of the National Academy of Sciences.

[25]  D. Cappellen,et al.  Netrin-1 acts as a survival factor for aggressive neuroblastoma , 2009, The Journal of experimental medicine.

[26]  E. Brambilla,et al.  Interference with netrin-1 and tumor cell death in non-small cell lung cancer. , 2009, Journal of the National Cancer Institute.

[27]  J. Scoazec,et al.  NF-kappaB regulates netrin-1 expression and affects the conditional tumor suppressive activity of the netrin-1 receptors. , 2008, Gastroenterology.

[28]  I. Treilleux,et al.  Netrin-1 expression confers a selective advantage for tumor cell survival in metastatic breast cancer , 2008, Proceedings of the National Academy of Sciences.

[29]  R. Coombes.  New targets for cancer therapy. , 1993, Molecular aspects of medicine.